Dysarthria < Dyskinesia, Drug-Induced < Dyskinesias

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 108.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000164 (2016)	N. Simon [France] ; F. Viallet [France] ; A. Boulamery [France] ; A. Eusebio [France] ; D. Gayraud [France] ; J-P Azulay [France]	A combined pharmacokinetic/pharmacodynamic model of levodopa motor response and dyskinesia in Parkinson's disease patients.
000170 (2016)	Annalisa Pinna [Italie] ; Wai Kin D. Ko [Royaume-Uni] ; Giulia Costa [Italie] ; Elisabetta Tronci [Italie] ; Camino Fidalgo [Italie] ; Nicola Simola [Italie] ; Qin Li [Royaume-Uni] ; Mojgan Aghazadeh Tabrizi [Italie] ; Erwan Bezard [Royaume-Uni] ; Manolo Carta [Italie] ; Micaela Morelli [Italie]	Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease.
000178 (2016)	Matthieu F. Bastide [France] ; Brice De La Crompe [France] ; Evelyne Doudnikoff [France] ; Pierre-Olivier Fernagut [France] ; Christian E. Gross [France] ; Nicolas Mallet [France] ; Thomas Boraud [France] ; Erwan Bézard [France]	Inhibiting Lateral Habenula Improves L-DOPA-Induced Dyskinesia.
000179 (2016)	Michael Feyder [Suède] ; Erik Södersten [Danemark] ; Emanuela Santini [Suède] ; Vincent Vialou [France] ; Quincey Laplant [États-Unis] ; Emily L. Watts [États-Unis] ; Giada Spigolon [Suède] ; Klaus Hansen [Danemark] ; Jocelyne Caboche [France] ; Eric J. Nestler [États-Unis] ; Gilberto Fisone [Suède]	A Role for Mitogen- and Stress-Activated Kinase 1 in L-DOPA-Induced Dyskinesia and ∆FosB Expression.
000180 (2016)	Michel Engeln [France] ; Matthieu F. Bastide [France] ; Estelle Toulmé [France] ; Benjamin Dehay [France] ; Mathieu Bourdenx [France] ; Evelyne Doudnikoff [France] ; Qin Li [République populaire de Chine] ; Christian E. Gross [France] ; Eric Boué-Grabot [France] ; Antonio Pisani [Italie] ; Erwan Bezard [France] ; Pierre-Olivier Fernagut [France]	Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA-Induced Dyskinesia.
000228 (2016)	Matthieu F. Bastide [France] ; Simone Bido [France] ; Nathalie Duteil [France] ; Erwan Bézard [France]	Striatal NELF-mediated RNA polymerase II stalling controls L-dopa induced dyskinesia.
000244 (2015)	Margarita Garcia-Amador [Espagne] ; Jessica Merchán-Naranjo ; Cecilia Tapia ; Carmen Moreno ; Josefina Castro-Fornieles ; Inmaculada Baeza ; Elena De La Serna ; José A. Alda ; Daniel Mu Oz ; Patricia Andrés Nestares ; Carmen Martínez Cantarero ; Celso Arango	Neurological Adverse Effects of Antipsychotics in Children and Adolescents.
000263 (2015)	Maude Beaudoin-Gobert [France] ; Léon Tremblay [France] ; Véronique Sgambato-Faure [France]	[An implication of serotonergic fibers which goes beyond Levodopa-induced dyskinesia].
000298 (2015)	Olivier Rascol [France] ; Santiago Perez-Lloret ; Joaquim J. Ferreira [Portugal]	New treatments for levodopa-induced motor complications.
000300 (2015)	Michel Engeln [France] ; Philippe De Deurwaerdère [France] ; Qin Li [République populaire de Chine] ; Erwan Bezard [République populaire de Chine] ; Pierre-Olivier Fernagut [France]	Widespread Monoaminergic Dysregulation of Both Motor and Non-Motor Circuits in Parkinsonism and Dyskinesia.
000302 (2015)	H. Iderberg [Suède] ; A C Mccreary [Pays-Bas] ; M A Varney [États-Unis] ; M S Kleven [France] ; W. Koek [France] ; L. Bardin [France] ; R. Depoortère [France] ; M A Cenci [Suède] ; A. Newman-Tancredi [États-Unis]	NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.
000308 (2015)	Matthieu F. Bastide [France] ; Wassilios G. Meissner [France] ; Barbara Picconi [Italie] ; Stefania Fasano [Italie] ; Pierre-Olivier Fernagut [France] ; Michael Feyder [Suède] ; Veronica Francardo [Suède] ; Cristina Alcacer [Suède] ; Yunmin Ding [États-Unis] ; Riccardo Brambilla [Italie] ; Gilberto Fisone [Suède] ; A. Jon Stoessl [Canada] ; Mathieu Bourdenx [France] ; Michel Engeln [France] ; Sylvia Navailles [France] ; Philippe De Deurwaerdère [France] ; Wai Kin D. Ko [France] ; Nicola Simola [Italie] ; Micaela Morelli [Italie] ; Laurent Groc [France] ; Maria-Cruz Rodriguez [Espagne] ; Eugenia V. Gurevich [États-Unis] ; Maryka Quik [États-Unis] ; Michele Morari [Italie] ; Manuela Mellone [Italie] ; Fabrizio Gardoni [Italie] ; Elisabetta Tronci [Italie] ; Dominique Guehl [France] ; François Tison [France] ; Alan R. Crossman [Royaume-Uni] ; Un Jung Kang [Suède] ; Kathy Steece-Collier [États-Unis] ; Susan Fox [Canada] ; Manolo Carta [Italie] ; M. Angela Cenci [Suède] ; Erwan Bézard [Royaume-Uni]	Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.
000325 (2015)	C. Fidalgo [Italie] ; W K D. Ko [Royaume-Uni] ; E. Tronci [Italie] ; Q. Li [République populaire de Chine] ; R. Stancampiano [Italie] ; Q. Chuan [République populaire de Chine] ; E. Bezard [République populaire de Chine] ; M. Carta [Italie]	Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease.
000352 (2015)	Nikhil M. Urs [États-Unis] ; Simone Bido [France] ; Sean M. Peterson ; Tanya L. Daigle ; Caroline E. Bass [États-Unis] ; Raul R. Gainetdinov [Russie] ; Erwan Bezard [France] ; Marc G. Caron [États-Unis]	Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.
000367 (2015)	Erwan Bezard [France] ; Manolo Carta [Italie]	Could the serotonin theory give rise to a treatment for levodopa-induced dyskinesia in Parkinson's disease?
000368 (2015)	Emma D. Deeks [Oman]	Safinamide: first global approval.
000390 (2015)	Marianne Amalric [France]	Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease.
000407 (2015)	Fanny Charbonnier-Beaupel [France] ; Marion Malerbi [France] ; Cristina Alcacer [France] ; Khadija Tahiri [France] ; Wassila Carpentier [France] ; Chuansong Wang [États-Unis] ; Matthew During [États-Unis] ; Desheng Xu ; Paul F. Worley ; Jean-Antoine Girault [France] ; Denis Hervé [France] ; Jean-Christophe Corvol [France]	Gene expression analyses identify Narp contribution in the development of L-DOPA-induced dyskinesia.
000434 (2015)	Mariza Bortolanza [Brésil] ; Roberta Cavalcanti-Kiwiatkoski [Brésil] ; Fernando E. Padovan-Neto [Brésil] ; Célia Aparecida Da-Silva [Brésil] ; Miso Mitkovski [Allemagne] ; Rita Raisman-Vozari [France] ; Elaine Del-Bel [Brésil]	Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease.
000467 (2014)	Cristina Alcacer [France] ; Fanny Charbonnier-Beaupel [France] ; Jean-Christophe Corvol [France] ; Jean-Antoine Girault [France] ; Denis Hervé [France]	Mitogen- and stress-activated protein kinase 1 is required for specific signaling responses in dopamine-denervated mouse striatum, but is not necessary for L-DOPA-induced dyskinesia.
000489 (2014)	Wai Kin D. Ko [France] ; Marie-Laure Martin-Negrier [France] ; Erwan Bezard [France] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni]	RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Dyskinesia, Drug-Induced" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Dyskinesia, Drug-Induced" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Dyskinesia, Drug-Induced
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024